These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18208572)

  • 21. Fosaprepitant: a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting.
    Navari RM
    Expert Rev Anticancer Ther; 2008 Nov; 8(11):1733-42. PubMed ID: 18983233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of intravenous infusion of glyceryl trinitrate on gastric and small intestinal motor function in healthy humans.
    Madsen JL; Fuglsang S; Graff J
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1251-7. PubMed ID: 16611287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical trial: effects of tegaserod on gastric motor and sensory function in patients with functional dyspepsia.
    Thumshirn M; Fruehauf H; Stutz B; Tougas G; Salter J; Fried M
    Aliment Pharmacol Ther; 2007 Nov; 26(10):1399-407. PubMed ID: 17892526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of 4 x 250 mg erythromycin on human gastrointestinal transit.
    Ueberschaer B; Ewe K; Alles U; Schmidtmann I
    Z Gastroenterol; 1995 Jul; 33(6):340-4. PubMed ID: 7668024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of a cellulose-containing weight-loss supplement on gastric emptying and sensory functions.
    Berthold HK; Unverdorben S; Degenhardt R; Unverdorben M; Gouni-Berthold I
    Obesity (Silver Spring); 2008 Oct; 16(10):2272-80. PubMed ID: 18719632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of the NK1 antagonist, aprepitant, on response to oral and intranasal oxycodone in prescription opioid abusers.
    Walsh SL; Heilig M; Nuzzo PA; Henderson P; Lofwall MR
    Addict Biol; 2013 Mar; 18(2):332-43. PubMed ID: 22260216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Small doses of the unabsorbable substance polyethylene glycol 3350 accelerate oro-caecal transit, but slow gastric emptying in healthy subjects.
    Coremans G; Vos R; Margaritis V; Ghoos Y; Janssens J
    Dig Liver Dis; 2005 Feb; 37(2):97-101. PubMed ID: 15733521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of aprepitant on the pharmacokinetics and pharmacodynamics of warfarin.
    Depré M; Van Hecken A; Oeyen M; De Lepeleire I; Laethem T; Rothenberg P; Petty KJ; Majumdar A; Crumley T; Panebianco D; Bergman A; de Hoon JN
    Eur J Clin Pharmacol; 2005 Jul; 61(5-6):341-6. PubMed ID: 15983826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of atilmotin on gastrointestinal transit in healthy subjects: a randomized, placebo-controlled study.
    Park MI; Ferber I; Camilleri M; Allenby K; Trillo R; Burton D; Zinsmeister AR
    Neurogastroenterol Motil; 2006 Jan; 18(1):28-36. PubMed ID: 16371080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of therapeutic doses of lactulose vs. polyethylene glycol on isotopic colonic transit.
    Jouët P; Sabate JM; Flourie B; Cuillerier E; Gambini D; Lemann M; Jian R; Coffin B
    Aliment Pharmacol Ther; 2008 May; 27(10):988-93. PubMed ID: 18284652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy.
    Yeo W; Mo FK; Suen JJ; Ho WM; Chan SL; Lau W; Koh J; Yeung WK; Kwan WH; Lee KK; Mok TS; Poon AN; Lam KC; Hui EK; Zee B
    Breast Cancer Res Treat; 2009 Feb; 113(3):529-35. PubMed ID: 18327706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aprepitant in adolescent patients for prevention of chemotherapy-induced nausea and vomiting: a randomized, double-blind, placebo-controlled study of efficacy and tolerability.
    Gore L; Chawla S; Petrilli A; Hemenway M; Schissel D; Chua V; Carides AD; Taylor A; Devandry S; Valentine J; Evans JK; Oxenius B;
    Pediatr Blood Cancer; 2009 Feb; 52(2):242-7. PubMed ID: 18985740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers.
    Camilleri M; Bharucha AE; Ueno R; Burton D; Thomforde GM; Baxter K; McKinzie S; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2006 May; 290(5):G942-7. PubMed ID: 16603730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized, placebo-controlled, pilot study evaluating aprepitant single dose plus palonosetron and dexamethasone for the prevention of acute and delayed chemotherapy-induced nausea and vomiting.
    Herrington JD; Jaskiewicz AD; Song J
    Cancer; 2008 May; 112(9):2080-7. PubMed ID: 18327813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose-response effect of a beta3-adrenergic receptor agonist, solabegron, on gastrointestinal transit, bowel function, and somatostatin levels in health.
    Grudell AB; Camilleri M; Jensen KL; Foxx-Orenstein AE; Burton DD; Ryks MD; Baxter KL; Cox DS; Dukes GE; Kelleher DL; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1114-9. PubMed ID: 18372395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of mosapride on esophageal motility and bolus transit in asymptomatic volunteers.
    Cho YK; Choi MG; Han HW; Park JM; Oh JH; Jeong JJ; Cho YS; Lee IS; Kim SW; Choi KY; Chung IS
    J Clin Gastroenterol; 2006 Apr; 40(4):286-92. PubMed ID: 16633098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opioid-like effects of the neurokinin 1 antagonist aprepitant in patients maintained on and briefly withdrawn from methadone.
    Jones JD; Speer T; Comer SD; Ross S; Rotrosen J; Reid MS
    Am J Drug Alcohol Abuse; 2013 Mar; 39(2):86-91. PubMed ID: 23421568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of itopride on gastric emptying in longstanding diabetes mellitus.
    Stevens JE; Russo A; Maddox AF; Rayner CK; Phillips L; Talley NJ; Giguère M; Horowitz M; Jones KL
    Neurogastroenterol Motil; 2008 May; 20(5):456-63. PubMed ID: 18179609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Omeprazole delays gastric emptying in healthy volunteers: an effect prevented by tegaserod.
    Tougas G; Earnest DL; Chen Y; Vanderkoy C; Rojavin M
    Aliment Pharmacol Ther; 2005 Jul; 22(1):59-65. PubMed ID: 15963081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Placebo- and amitriptyline-controlled evaluation of central nervous system effects of the NK1 receptor antagonist aprepitant and intravenous alcohol infusion at pseudo-steady state.
    te Beek ET; Tatosian D; Majumdar A; Selverian D; Klaassen ES; Petty KJ; Gargano C; van Dyck K; McCrea J; Murphy G; van Gerven JM
    J Clin Pharmacol; 2013 Aug; 53(8):846-56. PubMed ID: 23775877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.